文献速递肾癌与肾肿瘤

肾癌术后出院阿片类药物处方模式及相关医疗资源利用

Discharge Opioid Prescription Patterns After Kidney Cancer Surgery.
PubMed 文献 · Urology · 2021-02-06

基于SEER-Medicare数据,2007-2015年4538例接受部分或根治性肾切除术的肾癌患者中,出院阿片处方按口服吗啡当量 tertile 分为低(1-199)、中(200-300)、高(>300)三组。高剂量组与90天再入院(OR 1.21; CI 1.01-1.45)和长期阿片暴露(OR 1.34; CI 1.17-1.53)风险增加相关。

要点

  • 肾癌术后出院阿片处方剂量分布差异大,高剂量组占21.6%。
  • 高剂量阿片处方与90天再入院和长期阿片暴露风险升高相关。
  • 术前6个月内阿片暴露是术后高剂量处方和资源利用的重要关联因素。

核心结论

  • 肾癌术后阿片处方模式差异大,较高出院剂量与90天再入院和长期阿片暴露相关。
  • 术前阿片暴露与更高的医疗资源利用风险相关。
  • 更审慎的阿片处方可能有助于限制医疗资源利用并应对阿片危机。

研究设计与样本

  • 回顾性队列研究,使用SEER-Medicare关联数据。
  • 纳入2007-2015年接受部分或根治性肾切除术的肾癌患者4538例。
  • 按出院阿片处方口服吗啡当量 tertile 分为低(1-199)、中(200-300)、高(>300)三组。
  • 采用多因素logistic回归分析暴露组与人口学、临床因素及医院业务量的关联。

主要发现

  • 暴露组分布:低35%,中43.5%,高21.6%。
  • 39.5%的患者在术前6个月内接受过阿片处方。
  • 高剂量处方与既往阿片暴露、较年轻年龄、农村居住和开放手术相关(P < .001)。
  • 高剂量处方与90天再入院风险增加相关(OR 1.21; CI 1.01-1.45)。
  • 高剂量处方与长期阿片暴露风险增加相关(OR 1.34; CI 1.17-1.53)。

临床怎么用

  • 肾癌术后应审慎开具阿片类药物,尤其对术前已有阿片暴露者。
  • 高剂量出院阿片处方者需关注90天再入院和长期阿片使用风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe opioid prescribing patterns for patients undergoing kidney cancer surgery and evaluate associations with medical resource utilization in the postoperative setting. METHODS: Linked Surveillance, Epidemiology, and End Results - Medicare data were used to identify patients with kidney cancer who underwent partial or radical nephrectomy (open vs. minimally invasive) from 2007 to 2015. Total dose of discharge opioid prescriptions was quantified into 3 exposure groups based on observed tertiles: 1-199 (low), 200-300 (moderate), and >300 (high) oral morphine milligram equivalents. Associations between exposure groups and patient demographics, clinical factors, and hospital volumes were measured using multivariate logistic regression. Additionally, we identified associations with prior opioid exposure and postoperative medical resource utilization. RESULTS: Of 4538 patients meeting inclusion criteria, exposure group distributions were 35% (low), 43.5% (moderate) and 21.6% (high). Over one-third of patients (39.5%) received an opioid prescription within 6 months preceding surgery. High opioid prescriptions were associated with prior exposure, younger age, rural residence and open surgery (P < .001). High opioid prescriptions had increased risk of 90-day readmissions (OR 1.21; CI 1.01-1.45) and long-term opioid exposure (OR 1.34; CI 1.17-1.53). CONCLUSION: Prescribing patterns after kidney cancer surgery vary widely. Higher prescribed dose of post-surgical opioids is associated with 90-day hospital readmissions and long-term exposure. Prior opioid exposure conveys a higher risk of medical resource utilization. More judicious opioid prescribing may limit medical resource utilization and help combat the opioid epidemic.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Okoro C, Holt S, Ellison JS, et al. Discharge Opioid Prescription Patterns After Kidney Cancer Surgery. Urology. 2021. PMID: 33561469. doi:10.1016/j.urology.2020.12.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。